First Time Loading...

Silence Therapeutics PLC
NASDAQ:SLN

Watchlist Manager
Silence Therapeutics PLC Logo
Silence Therapeutics PLC
NASDAQ:SLN
Watchlist
Price: 23.35 USD 1.52% Market Closed
Updated: May 21, 2024

Silence Therapeutics PLC
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Silence Therapeutics PLC
Interest Income Expense Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Silence Therapeutics PLC
NASDAQ:SLN
Interest Income Expense
-£136k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Interest Income Expense
$570k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Interest Income Expense
-$29m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Interest Income Expense
$13.4m
CAGR 3-Years
N/A
CAGR 5-Years
125%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Interest Income Expense
-£344k
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Interest Income Expense
-£10.1m
CAGR 3-Years
N/A
CAGR 5-Years
-102%
CAGR 10-Years
-20%

See Also

What is Silence Therapeutics PLC's Interest Income Expense?
Interest Income Expense
-136k GBP

Based on the financial report for Dec 31, 2019, Silence Therapeutics PLC's Interest Income Expense amounts to -136k GBP.